calendula
Botanicalexperimental
Calendula is a genus of about 15–20 species of annual and perennial herbaceous plants in the daisy family, Asteraceae that are often known as marigolds. They are native to Europe, North Africa, Macaronesia and West Asia, and have their center of diversity in the Mediterranean Region. Other plants known as marigolds include corn marigold, desert marigold, marsh marigold, and plants of the genus Tagetes. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 12, 2015 (NCT03166423)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCalendula ↗
Also known as
- calendula
- calendula
- calendula
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05073172 | N/A | Dec 31, 2021 | OHSU Knight Cancer Institute, Oregon Health and Science University |
| NCT03166423 | Phase 1/Phase 2 (Phase 2) | Nov 12, 2015 | University of Chile |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| OHSU Knight Cancer Institute | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Chile | Academic/Hospital | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1